HCW Biologics Inc. - HCWB Real Price to Acquire Entire Company
The Separate Enterprise Value chart for HCW Biologics Inc. (HCWB) on the GURU.Markets platform is 8.37. HCW Biologics Inc. (HCWB) develops protein-based methods to combat oncology and aging via the TOPO system, allocating resources toward precise immune modulation. The business minimizes risks by activating the body's internal resources for the therapy of elderly patients. Success relies on test results and licensing payments amid stable capital.
&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_HCWB_-_HCW-Biologics-Inc._-_Enterprise-Value "HCWB HCW Biologics, Inc.: Total Company Value in the range 11/23/2025 - 10/28/2026 | 👁️GURU.Markets👁️")
HCW Biologics (HCWB) - metric breakdowns and financial figures
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:HCW Biologics Inc. (HCWB)
Enterprise Value (EV) sums market capitalization and net debt, determining the actual cost of a full business buyout inclusive of all liabilities. By analyzing the market valuation dynamics of HCW Biologics Inc. (HCWB), an investor can weigh the financial leverage against the value of its proprietary cGMP manufacturing facility in Florida, allowing for an objective assessment of the company's fundamental asset value regardless of stock volatility.
Competitor analysis for HCW Biologics Inc.
ARGX - Real Price to Acquire Entire Company|BNTX: Real Price to Acquire Entire Company|ABVX - Real Price to Acquire Entire Company|ADMA Biologics (ADMA) - Enterprise Value|PTGX (protagonist-inc.com) - Total Company Value|Total Company Value Immunovant IMVT|Full Business Value Kiniksa Pharmaceuticals, Ltd.|Grifols Group (GRFS) - Enterprise Value|Value Adjusted for Debt and Cash Adaptive Biotechnologies Inc. (ADPT)|Enterprise Value CLDX (Celldex Therapeutics)|auriniapharma.com - Enterprise Value|Total Company Value BioCryst Pharmaceuticals (BCRX)|VERA: Value Adjusted for Debt and Cash|DNTH (Dianthus Pharma) - Total Company Value|Pharvaris Pharma (PHVS) - Real Price to Acquire Entire Company|ABCL (AbCellera Biologics Inc) - Enterprise Value|Enterprise Value tourmalinebio.com (TRML)|Precigen (PGEN) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Pharming Group NV (PHAR)|Enterprise Value NKTR|Upstream Pharma - Company Buyout Price|ZBIO: Total Company Value|IMNM: Real Price to Acquire Entire Company|GOSS (Gossamer Bio) - Total Company Value|Real Price to Acquire Entire Company KalVista Pharma|SEPN (Septerna Corp) - Real Price to Acquire Entire Company|Enterprise Value PVLA|Total Company Value Savara Inc. SVRA|Business Value rigel.com (RIGL)|ANAB: Enterprise Value|Total Enterprise Value Astria Therapeutics Inc ATXS|Enterprise Value enGene Bio (ENGN)|RAPT - Value Adjusted for Debt and Cash|JBIO (aerovatetx.com) - Enterprise Value|Real Price to Acquire Entire Company aclaristx.com|Real Price to Acquire Entire Company KYTX|Real Price to Acquire Entire Company Tiziana Life Sciences Ltd. (TLSA)|Cabaletta Bio, Inc (CABA) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Ventyx Biosciences, Inc (VTYX)|Enterprise Value Theratechnologies Inc. THTX|Total Company Value avalotx.com AVTX|Enterprise Value ELDN (Eledon Pharmaceuticals, Inc.)|AGEN: Company Buyout Price|Total Company Value CLYM|ZURA (Zura Bio Ltd) - Total Enterprise Value|Total Company Value aTyr Pharma, Inc.|Total Company Value ADAG|ImageneBio Inc - Total Company Value|Total Enterprise Value shattucklabs.com (STTK)|EQ (Equillium) - Enterprise Value|Full Takeover Company Value Connect Biopharma Holdings CNTB|Enterprise Value IMUX (Immunic Inc)|ATRA - Company Buyout Price|IFRX (inflarx.de) - Enterprise Value|XFOR (X4 Pharmaceuticals Inc.) - Real Price to Acquire Entire Company|ACET: Total Company Value|Company Buyout Price Celularity Corp (CELU)|INmune Bio, Inc. (INMB) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash barinthusbio.com (BRNS)|Enterprise Value KZR|SAB Biotherapeutics Inc. - Company Buyout Price|Akari Therapeutics plc (AKTX) - Total Company Value|ENLV - Business Value|QTTB (q32bio.com) - Enterprise Value|Real Price to Acquire Entire Company geovax.com|EDSA: Real Price to Acquire Entire Company|Company Buyout Price iBio Inc|Carisma Therapeutics (CARM) - Enterprise Value|Value Adjusted for Debt and Cash XTL Bio (XTLB)|Bolt Biotherapeutics, Inc. - Enterprise Value|APVO - Real Price to Acquire Entire Company|AIM: Real Price to Acquire Entire Company|ADTX - Real Price to Acquire Entire Company|GRI Bio Corp (GRI) - Enterprise Value|XRTX (XORTX Corp) - Total Company Value|Total Company Value Vyome Holdings Inc HIND|Full Business Value revbiosciences.com|Indaptus Therapeutics, Inc. (INDP) - Enterprise Value|Value Adjusted for Debt and Cash Scinai Immunotherapeutics Ltd (SCNI)|Enterprise Value CALI (CalciMedica)|Affimed NV - Enterprise Value|Total Company Value Allakos Therapeutics (ALLK)|HOOK: Value Adjusted for Debt and Cash|IGMS (igmbio.com) - Total Company Value|iTeos Therapeutics Inc (ITOS) - Real Price to Acquire Entire Company|OCEA (Ocean Bio) - Enterprise Value|Enterprise Value TC BioPharm Ltd (TCBP)|Third Harmonic Bio (THRD) - Real Price to Acquire Entire Company